OrphanPacific, Inc. Exhibited and Presented at World Orphan Drug Congress USA 2019
OrphanPacific Inc., the pharmaceutical affiliate of CMIC Group, the largest CRO in Japan with end-to-end Pharmaceutical Value Creator solutions, have exhibited at World Orphan Drug Congress USA 2019 which was held in Gaylord National Resort & Convention Center, Washinton DC, from April 10, 2019 throgh April 12, 2019 .
In this meeting, Philippe Auvaro, President of OrphanPacific, Inc. and Executive Vice President of CMIC HOLDINGS, havel presented
“JAPAN: leveraging a comprehensive value creation platform to successfully enter and navigate the Japanese rare disease market.”
on Thursday April 11th.
Mr. Auvaro have talked about how CMIC group offers an unique solution platform to enter Japanese orphan drugs market and how OrphanPacific can support market introduction, logistic and promotion in the rare disease areas.
For the presentation, please access here.
For any questions or inquiry, please contact OrphanPacific, Inc.